To investigate the levels of platelet reactivity and the impact of high platelet reactivity (HPR) on long-term clinical outcomes of complex higher-risk and indicated patients (CHIP) with stable coronary artery disease (CAD) treated with elective percutaneous coronary intervention (PCI).
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients
Mangiacapra, Fabio;Spoto, Silvia;Di Sciascio, Germano;Ussia, Gian Paolo;Grigioni, Francesco
2022-01-01
Abstract
To investigate the levels of platelet reactivity and the impact of high platelet reactivity (HPR) on long-term clinical outcomes of complex higher-risk and indicated patients (CHIP) with stable coronary artery disease (CAD) treated with elective percutaneous coronary intervention (PCI).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
20.500.12610-67121.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
2.86 MB
Formato
Adobe PDF
|
2.86 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
